Latest news
CSL Says European Commission Revokes Marketing Authorization for Tavneos - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 00:25:17 GMTCSL : European Commission (EC) adopts decision to revoke marketing authorisation for TAVNEOS® (avacopan) in the European Union and European Economic Area countries - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 06:22:11 GMTAmgen (AMGN) Faces Patient Data Breach And Tavneos Review Risk - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 03:19:00 GMTLiver Failure: Amgen Continues Marketing Avacopan (Tavneos) in the United States - The National Law ReviewThe National Law Review · Tue, 04 Aug 2026 12:20:35 GMTTGA to review the benefits and risks of Tavneos - The Pharma LetterThe Pharma Letter · Mon, 03 Aug 2026 15:56:39 GMTAmgen makes its case for hearing to keep Tavneos on the US market - bioworld.combioworld.com · Tue, 28 Jul 2026 16:00:00 GMTAmgen stock jumps as investors appear to look past Tavneos overhang and toward earnings - Quiver QuantitativeQuiver Quantitative · Tue, 28 Jul 2026 14:53:00 GMTAmgen makes case to continue selling drug that FDA links to deaths - The Business JournalsThe Business Journals · Tue, 28 Jul 2026 07:00:00 GMT